Thomas Brooks

Healthcare Capital Partners LLC (Healthcare Capital) is a venture capital firm founded in 2003 by Bruce Bishop and Thomas Brooks. The firm is headquartered in Atlanta, Georgia.

MitralSolutions is developing innovative, implantable devices that repair heart valve abnormalities. MitralSolutions believes that there are substantial market opportunities in both the surgical and percutaneous applications and is developing a product portfolio that will address treating a greater number of patients earlier in their disease cycle, providing an improved quality of life.

EpiEP, Inc. develops heart-related medical devices. It has developed epicardial access system, EpiAccess, which engages a patent protected pressure-guided needle that is designed to alert physicians of needle tip location during epicardial access procedures. The firm specializes on instruments that facilitates an epicardial approach for patients who benefit from minimally invasive procedures on the surface of the heart. The company was founded by Pamela M. Bunes, Jason Tucker-Schwartz, Srijoy Mahapatra and George T. Gillies in December 2008 and is headquartered in New Haven, CT.

Valeo Medical, Inc. develops non-invasive serum diagnostic for endometriosis, a chronic painful disease that affects women of child-bearing age. It products address the needs of millions of women who suffer with endometriosis. The company was founded by Frederick J. Fritz & Debra A. Peattie in 2003 and is located in Burlington, MA.

Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH.

Founded in 1994, The Cypress Group LLC is a private equity firm based in New York, US.

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.